Health Care & Life Sciences » Biotechnology | CK Life Sciences International

CK Life Sciences International | Mutual Funds

Mutual Funds that own CK Life Sciences International

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
DFA Asia Pacific Small Company Series
22,972,000
0.24%
0
0.07%
01/31/2018
iShares MSCI EAFE Small Cap ETF
22,074,000
0.23%
0
0.01%
09/06/2018
DFA International Core Equity Portfolio
11,806,000
0.12%
0
0%
04/30/2018
iShares Core MSCI EAFE ETF
9,780,000
0.1%
0
0%
09/06/2018
SPDR S&P International Small Cap ETF
2,764,000
0.03%
0
0.02%
09/06/2018
CREF Stock Account
2,328,000
0.02%
668,000
0%
03/31/2018
Metropolitan Series - Met/Dimensional Intl. Small Company Por.
1,594,000
0.02%
0
0.02%
03/31/2018
Dimensional Funds Plc - Global Targeted Value Fund
1,510,023
0.02%
347,093
0%
11/30/2017
DFA International Vector Equity Portfolio
1,358,000
0.01%
0
0%
04/30/2018
DFA TA World (ex-US) Core Equity Portfolio
1,286,000
0.01%
0
0%
04/30/2018

About CK Life Sciences International

View Profile
Address
2 Dai Fu Street
Hong Kong
Hong Kong
Employees -
Website http://www.ck-lifesciences.com
Updated 07/08/2019
CK Life Sciences International (Holdings), Inc. operates as an investment company, which engages in the business of research and development, manufacturing, commercialization, marketing and selling of products and assets in nutraceuticals, pharmaceuticals and agriculture related business. It operates through the following segments: Agriculture-Related, Health, and Investment. The company was founded on August 10, 2001 and is headquartered in Hong Kong.